Welcome
Welcome to the Department of Clinical Neurosciences.
Our mission is to understand the nervous system in health and disease in order to develop new treatments for incurable neurological disorders.
We are embedded within Cambridge University Hospitals, allowing our research questions to stem from problems we have encountered in the clinic, and to directly address the needs of patients and families. Working in close partnership with the Departments of Psychiatry, Genetics and Paediatrics, we are determining how genetics and the environment interact to cause the major brain diseases that impact childhood to old-age. Our work unravelling the mechanisms of brain disease has led to new treatments which we have tested in the clinic and are now in use world-wide.
Case Study – Head First…
Our major international strengths include;
- Include immunological treatments against brain inflammation including multiple sclerosis,
- Surgical and metabolic interventions to reduce the impact of head injury,
- Understanding the causes and consequences of stroke,
- Preventing the loss of vision and hearing, and
- Developing new treatments to stop neurodegeneration and dementias including Parkinson’s disease and Alzheimer’s disease.
Case Study – In with the new…
We use innovative cross-cutting technologies that bridge between the laboratory and the clinic, including genetics and genomics to study rare and common neurological diseases, cell biology and human stem cells, model organisms, and state-of-the-art human brain imaging through the Department hosted Wolfson Brain Imaging Centre and the UK Dementia Research Institute centre.
Featured News
The neuroscientist hoping to slow down dementia and speed up Darwin
When she’s not on the river captaining the Darwin College Boat Club, PhD student Jessica Walsh is investigating a possible…
Promising molecule targets protein to offer hope for people with Parkinson’s
Results indicate that early treatment to tackle alpha-synuclein clumps can restore dopamine levels and stop the condition in its tracks…
New research group to help discoveries benefit patients
For Dementia Action Week on International Clinical Trials Day 2019, a unique research group has been launched to test promising…
Patrick Chinnery appointed as MRC Clinical Director
Congratulations to Patrick Chinnery who has been appointed as MRC Clinical Director He joins the senior management team and will…
Honour awarded to Professor Maria Grazia Spillantini
Professor Maria Grazia Spillantini received the honour of Officer of the Order of the Star of Italy (Ufficiale OSI). The…